NCT06823804

Brief Summary

In the treatment of critically ill patients, mechanical ventilation is a key link, and appropriate mechanical ventilation strategies can open the alveoli and improve oxygenation, while inappropriate mechanical ventilation can increase lung injury and seriously affect the prognosis. Ventilator-related lung injury is mainly concentrated in barotrauma, volumetric injury, shear injury, and biological injury, and the monitoring of respiratory ventilation to the level of local ventilation can help to better assess the state of alveolar opening and alveolar collapse, and help to understand the uniformity of gas distribution in the lungs, which is closely related to lung injury. However, how to achieve simple, bedside and real-time lung ventilation and lung volume assessment in clinical work has always been a difficult problem to be overcome. This study intends to explore the changes of local ventilation and blood flow in the lungs during PEEP trail in patients with ARDS monitored by EIT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

December 25, 2024

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 12, 2025

Completed
Last Updated

April 23, 2026

Status Verified

December 1, 2024

Enrollment Period

2.1 years

First QC Date

December 25, 2024

Last Update Submit

April 20, 2026

Conditions

Keywords

ventilation/perfusion ratioElectrical impedance tomographyAcute Respiratory Distress Syndrome

Outcome Measures

Primary Outcomes (1)

  • recruitment success percent

    recruitment( ≥10% compliance improvement ) and Re-check the blood gas ≥20 mmHg PaO₂/FiO₂ increase mean success

    From enrollment to the end of treatment at 7 days

Secondary Outcomes (4)

  • 28-day mortality

    From enrollment to the end of treatment at 28 days

  • Ventilator-free days at Day 28

    From enrollment to the end of treatment at 28 days

  • Length of ICU stay

    From enrollment to the end of treatment at 7 days

  • Change in Sequential Organ Failure Assessment (SOFA) score from baseline to day 7

    From enrollment to the end of treatment at 7 days

Study Arms (1)

evaluate the feasibility of using EIT to calculate regional recruitment-to-inflation (R/I) ratios

Regional R/I ratios were computed for the global lung, dorsal (dependent), and ventral (non-dependent) regions of interest (ROIs), which were defined as 50% of the ventro-dorsal lung diameter based on EIT imaging.compare the predictive value of regional (dorsal and ventral) versus global R/I for recruitment success in moderate-severe ARDS.

Diagnostic Test: Electrical Impedance tomography Monitoring

Interventions

Standardized PEEP step maneuver from 5 → 15 cmH₂O, maintained for 3 minutes. Continuous EIT monitoring of regional compliance, oxygenation, hemodynamics. Dynamic strain cutoff (\>0.6) or adverse events terminate the maneuver. Ventilation mode: volume control, tidal volume 4-6 mL/kg predicted body weight, plateau ≤28-30 cmH₂O, FiO₂ titrated for SpO₂ 88-92%.

evaluate the feasibility of using EIT to calculate regional recruitment-to-inflation (R/I) ratios

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study included adult patients (≥18 years) with moderate-to-severe acute respiratory distress syndrome (ARDS) who were receiving invasive mechanical ventilation in the intensive care unit (ICU) of Ruijin Hospital. All enrolled patients met the Berlin definition of ARDS and had a PaO₂/FiO₂ ratio ≤200 mmHg within 6 hours of screening. A total of 120 patients were consecutively enrolled from December 2022 to December 2024. Patients were stratified by airway closure status for subgroup analyses.

You may qualify if:

  • Patients who meet the Berlin definition of ARDS and have been treated with mechanical ventilation (clinical diagnosis of ARDS by the attending ICU physician)
  • PaO₂/FiO₂ ≤200 mmHg

You may not qualify if:

  • Age\< 18 or \>90 years
  • Pneumothorax, pneumomediastinum
  • Hemodynamic instability (rising vasopressor need in \<6h)
  • Contraindications to RM or EIT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China.

Shanghai, Shanghai Municipality, 200025, China

Location

MeSH Terms

Conditions

Respiratory AspirationRespiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsLung Diseases

Study Officials

  • Hongping Qu

    Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

    STUDY CHAIR
  • Jialin Liu

    Department of Geriatrics,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR
  • rui zhang

    Department of Critical Care Medicine,Ruijin Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 25, 2024

First Posted

February 12, 2025

Study Start

December 1, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 23, 2026

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations